Core Viewpoint - Aktis Oncology, Inc. has successfully closed its upsized initial public offering (IPO) of 17,650,000 shares at a price of $18.00 per share, with additional shares bringing total gross proceeds to approximately $365.4 million [1]. Company Overview - Aktis Oncology is a clinical-stage oncology company focused on targeted radiopharmaceuticals aimed at large patient populations, including those not served by existing technologies [4]. - The company's advanced pipeline program targets Nectin-4, utilizing a miniprotein radioconjugate platform designed to deliver radioisotopes selectively to tumors while minimizing side effects [4]. - Aktis' platform is isotope-agnostic, allowing for visualization and verification of target engagement with imaging isotopes before therapeutic exposure [4]. - The company has a strategic collaboration with Eli Lilly and Company to develop novel radioconjugates beyond its proprietary pipeline [4]. IPO Details - The IPO was completed on January 12, 2026, with the underwriters fully exercising their option to purchase an additional 2,647,500 shares, expected to close on January 14, 2026 [1]. - The total gross proceeds from the IPO, including the additional shares, are anticipated to be around $365.4 million before deducting underwriting discounts and commissions [1]. - Aktis' common stock began trading on the Nasdaq Global Select Market under the ticker symbol "AKTS" on January 9, 2026 [1].

Company Overview - Bleichroeder Acquisition Corp. II has successfully closed its initial public offering (IPO) of 28,750,000 units, generating gross proceeds of $287,500,000 at a price of $10.00 per unit [1][3] - The company is a blank check entity aimed at pursuing mergers, amalgamations, share exchanges, asset acquisitions, or similar business combinations, primarily focusing on North American and European businesses in disruptive growth sectors [4] IPO Details - The units began trading on January 8, 2026, on the Nasdaq Global Market under the ticker symbol "BBCQU," with each unit comprising one Class A ordinary share and one-third of a redeemable warrant [2] - Each whole warrant allows the holder to purchase one Class A ordinary share at a price of $11.50 per share, with separate trading expected for the Class A ordinary shares and warrants under the symbols "BBCQ" and "BBCQW," respectively [2] Management and Structure - The management team includes Co-Founders Michel Combes and Andrew Gundlach, along with CFO Robert Folino and COO Marcello Padula, supported by board members Kathy Savitt and Antoine Theysset [4] - Cohen & Company Capital Markets served as the Lead Book-Running Manager, while Clear Street acted as Co-Manager for the offering [5]

Core Viewpoint - JPMorgan is expected to report strong fourth-quarter and full-year 2025 earnings, with significant attention on its performance as a bellwether for the financial sector [1] Group 1: Earnings Performance - JPMorgan's nine-month performance was driven by strong investment banking and trading, with a projected revenue of $45.71 billion for Q4, indicating a 6.9% year-over-year rise [2] - The consensus estimate for fourth-quarter earnings has increased to $5.01, reflecting a 4.2% rise from the previous year [3] - The company has a history of exceeding earnings estimates, with an average surprise of 11.01% over the last four quarters [5] Group 2: Revenue Drivers - Net Interest Income (NII) is expected to reach nearly $25 billion in Q4, with a full-year estimate of approximately $95.8 billion, suggesting a 6.8% year-over-year increase [8] - Investment Banking (IB) revenues are projected to rise 4.2% year-over-year, with a consensus estimate of $2.71 billion [11] - Markets revenues are anticipated to grow at a low-teens percentage rate year-over-year, with equity markets revenues expected to jump 38.2% [13] Group 3: Expenses and Asset Quality - Operating expenses are projected to increase by 7.2% year-over-year to $24.4 billion due to expansion efforts and technology investments [16] - The provision for credit losses is estimated at $1.66 billion, down 36.7% year-over-year, excluding provisions related to the Apple Card acquisition [18] - Non-performing loans (NPLs) are expected to rise by 19.4% year-over-year, indicating potential asset quality pressures [18] Group 4: Market Position and Valuation - JPMorgan's shares have underperformed compared to the S&P 500 and peers like Citigroup and Bank of America, with a forward P/E of 15.67X, above the industry average [21][24] - The company benefits from its scale and diversified operations, with ongoing initiatives expected to drive growth despite elevated expenses [28] - Investors are advised to monitor management's guidance on NII and IB outlook during the upcoming earnings call [29]

Core Viewpoint - Soren Acquisition Corp. successfully closed its initial public offering (IPO) of 25,300,000 units, generating gross proceeds of $253 million, with a focus on pursuing business combinations in the healthcare industry [1][3]. Group 1: IPO Details - The IPO was priced at $10.00 per unit, resulting in gross proceeds of $253 million [1]. - The units began trading on January 7, 2026, on the Nasdaq under the ticker symbol "SORNU" [2]. - Each unit consists of one Class A ordinary share and one-third of a redeemable warrant, with each whole warrant allowing the purchase of one Class A ordinary share at an exercise price of $11.50 [2]. Group 2: Company Structure and Management - Soren Acquisition Corp. is a blank check company aimed at merging or acquiring businesses, particularly in the healthcare sector [3]. - The management team includes CEO Arghavan Di Rezze and CFO Jamie Weber, along with other board members [4]. Group 3: Legal and Advisory Support - BTIG, LLC acted as the sole book-running manager for the offering, while Reed Smith LLP served as legal counsel to the company [5]. - Walkers (Cayman) LLP provided legal counsel in the Cayman Islands, and Ellenoff Grossman & Schole LLP represented the underwriter [5].

Core Viewpoint - Lafayette Digital Acquisition Corp. I has announced the pricing of its initial public offering (IPO) of 25,000,000 units at $10.00 per unit, with each unit consisting of one Class A ordinary share and one-fourth of a redeemable warrant [1] Group 1: IPO Details - The IPO consists of 25,000,000 units priced at $10.00 each, with each unit including one Class A ordinary share and one-fourth of a redeemable warrant [1] - Each whole warrant can be exercised 30 days after the completion of the initial business combination, allowing the holder to purchase one Class A ordinary share at $11.50 per share [1] - The units are expected to begin trading on Nasdaq under the ticker symbol "ZKPU" starting January 9, 2026 [1] Group 2: Underwriting and Closing - BTIG, LLC is acting as the sole book-running manager for the offering [2] - The underwriter has a 45-day option to purchase up to an additional 3,750,000 units at the initial public offering price to cover over-allotments [2] - The offering is expected to close on January 12, 2026, subject to customary closing conditions [2] Group 3: Company Overview - Lafayette Digital Acquisition Corp. I is a special purpose acquisition company (SPAC) formed to effect a merger or similar business combination with one or more businesses, primarily focusing on the technology industry [5] - The management team is led by Samuel A. Jernigan IV, who serves as the Chief Executive Officer and Chairman of the Board of Directors [5]

As filed with the U.S. Securities and Exchange Commission on January 8, 2026. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ___________________________ Cantor Equity Partners VI, Inc. (Exact name of registrant as specified in its charter) ___________________________ | Cayman Islands | 6770 | 98-1601080 | | --- | --- | --- | | (State or other jurisdiction of | (Primary Standard Industrial | (I.R.S ...

Company Overview - Bleichroeder Acquisition Corp. II is a blank check company formed to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses [2] - The company will primarily focus on acquisition opportunities in North American and European businesses within disruptive growth sectors, particularly those transformed by technology adoption [2] Initial Public Offering (IPO) Details - The company announced the pricing of its initial public offering of 25,000,000 units, expected to begin trading on Nasdaq under the ticker symbol "BBCQU" on January 8, 2026 [1] - Each unit consists of one Class A ordinary share and one-third of one redeemable warrant, with each whole warrant allowing the purchase of one Class A ordinary share at a price of $11.50 per share [1] - The offering is expected to close on January 9, 2026, subject to customary closing conditions, and underwriters have a 45-day option to purchase an additional 3,750,000 units to cover over-allotments [1] Management Team - The management team is led by Co-Founders Michel Combes and Andrew Gundlach, along with Chief Financial Officer Robert Folino and Chief Operating Officer Marcello Padula [2] - The Board includes Kathy Savitt and Antoine Theysset [2] Offering Management - Cohen & Company Capital Markets and Clear Street are acting as co-managers for the offering [3]

Company Overview - Soren Acquisition Corp. is a blank check company formed to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses, focusing on the healthcare industry [2]. Initial Public Offering (IPO) Details - The company announced the pricing of its initial public offering of 22,000,000 units at a price of $10.00 per unit, with trading expected to begin on January 7, 2026, under the ticker symbol "SORNU" [1]. - Each unit consists of one Class A ordinary share and one-third of one redeemable warrant, with each whole warrant allowing the purchase of one Class A ordinary share at a price of $11.50 per share [1]. - The offering is expected to close on January 8, 2026, subject to customary closing conditions, and underwriters have a 45-day option to purchase an additional 3,300,000 units to cover over-allotments [1]. Management Team - The management team is led by Arghavan Di Rezze (CEO) and Jamie Weber (CFO), both of whom are members of the Board of Directors, which also includes Marc Mazur, Charles N. Khan III, and Spencer Gerrol [3]. Underwriters and Legal Counsel - BTIG, LLC is acting as the sole book-running manager for the offering, while Reed Smith LLP and Walkers (Cayman) LLP serve as legal counsel to the company [4].

Core Viewpoint - PicPay has filed a registration statement with the U.S. Securities and Exchange Commission for a proposed initial public offering of its Class A common shares, with details on the number of shares and price range yet to be determined [1] Company Summary - The offering is subject to market conditions and the completion of the SEC review process [1] - If the offering is completed, PicPay intends to list its Class A common shares [1]

Core Insights - Indian equities are experiencing their largest underperformance against Asian peers in nearly 30 years, driven by a weak rupee and significant foreign outflows [1][2] - Foreign funds withdrew $1.7 billion in December, leading to a record annual outflow of $17.9 billion [1] - The NSE Nifty 50 Index is on track for its biggest annual underperformance since the late 1990s, with a 0.8% decline in December [3] Market Performance - Despite recent challenges, India's stock market is set to achieve a 10th consecutive year of gains, supported by local institutional investments of approximately $81 billion in 2025 [3] - The Nifty 50 Index has historically shown a tendency to decline in January, averaging a loss of 1.1% [4] Future Outlook - Strategists from Nomura and Citigroup anticipate further gains for Indian equities in 2026, contingent on improving corporate earnings and effective domestic demand policies [4] - The IPO market is expected to remain robust, with forecasts suggesting proceeds will exceed $25 billion in the upcoming year [5]